Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale EVP, Pres. Discovery&Research sold 41,666 shares at $3.68 ($153,214)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale EVP, Pres. Discovery&Research sold 10,000 shares at $3.75 ($37,518)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4/A Open-market sale EVP Corp. Affairs, G.C., Sect. sold 1,000 shares at $2.22 ($2,220)
  18. 4 Open-market sale EVP Corp. Affairs, G.C., Sect. sold 1,000 shares at $2.22 ($2,220)
  19. 4 Open-market sale EVP, Pres. Discovery&Research sold 20,000 shares at $2.56 ($51,200)
  20. 4 Derivatives Options or other derivatives

Page 15 of 34 · 664 filings